Jonathan Hu, MD
Retina Specialist · Gainesville, FLNPI 1831461458
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.6%), food and beverage and gifts — rather than concentrated in one kind of arrangement. Spark Therapeutics, Inc. accounts for 65.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $1,239 and has fallen 97.7% since, to $28 in 2025. That places this record below the midpoint for retina specialist clinicians in FL, where the typical reported total is $2,986.
Across 15 payments — averaging $114.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spark Therapeutics, Inc.$1K
- Novartis$198
- Apellis Pharmaceuticals, Inc.$119
- Omeros Corporation$118
- Aerie Pharmaceuticals, Inc.$97
- Tarsus Pharmaceuticals, Inc.$28
- plus $32 from 2 others
Across 1 payment — averaging $5070.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ophtec USA, Inc.$5K
What the payments were for
- Travel & lodging$93555%
- Food & beverage$75944%
- Gifts$191%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spark Therapeutics, Inc. | 7 | $1,120 |
| Novartis | 2 | $198 |
| Apellis Pharmaceuticals, Inc. | 1 | $119 |
| Omeros Corporation | 1 | $118 |
| Aerie Pharmaceuticals, Inc. | 1 | $97 |
| Tarsus Pharmaceuticals, Inc. | 1 | $28 |
| Carl Zeiss Meditec AG | 1 | $19 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,713 in reported general payments places this provider in the 35th percentile of 118 retina specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 11 | $8,171 |
| Prednisolone Acetate | 76 | $3,788 |
| MoxifloxacinMoxifloxacin Hcl | 46 | $1,396 |
| Ketorolac Tromethamine | 18 | $753 |
| Timolol Maleate | 35 | $368 |
| Brimonidine Tartrate | 55 | $350 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 27 | $312 |
| Latanoprost | 25 | $255 |
| Dorzolamide Hcl | 15 | $197 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $12 | $8,17111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 118 retina specialist providers in Florida.
Other retina specialist in Gainesville
- Michael ParrottGainesville$13K
- Sunil GuptaPensacola$1.8M
- Joseph NezgodaWest Palm Beach$600K
- Eduardo UchiyamaFt Lauderdale$356K
- Thomas AlbiniMiami$281K
- Audina BerrocalMiami$210K
- Philip RosenfeldMiami$206K
- John MyersPensacola$152K
- Timothy MurraySouth Miami$133K
- Adiel SmithAventura$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.